Editorial: HDAC inhibition begets more MDSCS

Journal of Leukocyte Biology

Volumn 91, Issue 5, 2012, Pages 679-681

  Reddy, Pavan ^a  

^a UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

Histone Deacetylases; Immune Response; Myeloid Cells

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE;

BONE MARROW CELL; CELL DIFFERENTIATION; EDITORIAL; HEMATOPOIETIC STEM CELL; MYELOID DERIVED SUPPRESSOR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SUPPRESSOR CELL;

ANIMALS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HYDROXAMIC ACIDS; MALE; MYELOID CELLS;

EID: 84860905239     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1111541     Document Type: Editorial

References (27)

1. Dinarello, C. A., Fossati, G., Mascagni, P. (2011) Histone deacetylase inhibitors for treating a spectrum of diseases not related to cancer. Mol. Med. 17, 333-352.
2. Leoni, F., Zaliani, A., Bertolini, G., Porro, G., Pagani, P., Pozzi, P., Dona, G., Fossati, G., Sozzani, S., Azam, T., Bufler, P., Fan-tuzzi, G., Goncharov, I., Kim, S. H., Pomer-antz, B. J., Reznikov, L. L., Siegmund, B., Dinarello, C. A, Mascagni, P. (2002) The antitumor histone deacetylase inhibitor sub-eroylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines. Proc. Natl. Acad. Sci. USA 99, 2995-3000.
3. Rosborough, B. R., Castellaneta, A, Natara-jan, S., Thomson, A. W., Turnquist, H. R (2011) Histone deacetylase inhibition facilitates GM-CSF-mediated expansion of myeloid-derived suppressor cells in vitro and in vivo. J. Leukoc. Biol., 91, 701-709.
4. Condamine T, Gabrilovich, D. I. (2011) Molecular mechanisms regulating myeloid-de-rived suppressor cell differentiation and function. Trends Immunol. 32, 19-25.
5. Narlikar, G. J., Fan, H. Y., Kingston, R E. (2002) Cooperation between complexes that regulate chromatin structure and transcription. Cell 108, 475-487.
6. Kouzarides, T. (2007) Chromatin modifications and their function. Cell 128, 693-705.
7. Yang, X-J., Seto, E. (2008) Lysine acetylation: codified crosstalk with other posttranslational modifications. Mol. Cell 31, 449-461.
8. Kouzarides, T. (2000) Acetylation: a regulatory modification to rival phosphorylation? EMBO J. 19, 1176-1179.
9. Yuan, Z. L., Guan, Y J., Chatterjee, D., Chin, Y E. (2005) Stat3 dimerization regulated by reversible acetylation of a single lysine residue. Science 307, 269-273.
10. Sun, Y, Chin, Y E., Weisiger, E., Malter, C, Tawara, I., Toubai, T, Gatza, E., Mascagni, P., Dinarello, C. A, Reddy, P. (2009) Cutting edge: negative regulation of dendritic cells through acetylation of the nonhistone protein STAT-3. J. Immunol 182, 5899-5903.
11. Johnstone, R W. (2002) Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat. Rev. Drug Discov. 1, 287-299.
12. Haberland, M., Montgomery, R. L., Olson, E. N. (2009) The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat. Rev. Genet. 10, 32-42.
13. Beier, U. H., Akimova, T., Liu, Y, Wang, L., Hancock, W. W. (2011) Histone/protein deacetylases control Foxp3 expression and the heat shock response of T-regulatory cells. Curr. Opin. Immunol. 23, 670-678.
14. Beier, U. H., Wang, L., Bhatti, T. R, Liu, Y, Han, R, Ge, G., Hancock, W. W. (2011) Sir-tuin-1 targeting promotes Foxp3+ T-regulatory cell function and prolongs allograft survival. Mol. Cell. Biol. 31, 1022-1029.
15. De Zoeten, E. F., Wang, L., Butler, K, Beier, U. H., Akimova, T., Sai, H., Bradner, J. E., Mazitschek, R, Kozikowski, A. P., Matthias, P., Hancock, W. W. (2011) Histone deacetylase 6 and heat shock protein 90 control the functions of Foxp3(+) T-regulatory cells. Mol. Cell. Biol. 31, 2066-2078.
16. Finnin, M. S., Donigian, J. R, Cohen, A, Richon, V. M., Rifkind, R A., Marks, P. A, Breslow, R, Pavletich, N. P. (1999) Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature 401, 188-193.
17. Reddy, P., Maeda, Y., Hotary, K., Liu, C., Reznikov, L. L., Dinarello, C. A., Ferrara, J. L. (2004) Histone deacetylase inhibitor suberoylani-lide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect. Proc. Natl. Acad. Sci. USA 101, 3921-3926.
18. Tao, R., de Zoeten, E. F., Ozkaynak, E., Chen, C., Wang, L., Porrett, P. M., Li, B., Turka, L. A., Olson, E. N., Greene, M. I., Wells, A. D., Hancock, W. W. (2007) Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat. Med. 13, 1299-1307.
19. Reddy, P., Sun, Y., Toubai, T., Duran-Struuck, R., Clouthier, S. G., Weisiger, E., Maeda, Y., Tawara, I., Krijanovski, O., Gatza, E., Liu, C., Malter, C., Mascagni, P., Dinarello, C. A., Fer-rara, J. L. (2008) Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice. J. Clin. Invest. 118, 2562-2573.
20. Roger, T., Lugrin, J., Le Roy, D., Goy, G., Mom-belli, M., Koessler, T., Ding, X. C., Chanson, A. L., Reymond, M. K., Miconnet, I., Schrenzel, J., Francois, P., Calandra, T. (2011) Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection. Blood 117, 1205-1217.
21. Brogdon, J. L., Xu, Y., Szabo, S. J., An, S., Buxton, F., Cohen, D., Huang, Q. (2007) Histone deacety-lase activities are required for innate immune cell control of Th1 but not Th2 effector cell function. Blood 109, 1123-1130.
22. Umemura, N., Saio, M., Suwa, T., Kitoh, Y., Bai, J., Nonaka, K., Ouyang, G. F., Okada, M., Balazs, M., Adany, R., Shibata, T., Takami, T. (2008) Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics. J. Leukoc. Biol. 83, 1136-1144.
23. Gabrilovich, D. I., Nagaraj, S. (2009) My-eloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9, 162-174.
24. Highfill, S. L., Rodriguez, P. C., Zhou, Q., Goetz, C. A., Koehn, B. H., Veenstra, R., Taylor, P. A., Panoskaltsis-Mortari, A., Se-rody, J. S., Munn, D. H., Tolar, J., Ochoa, A. C., Blazar, B. R. (2010) Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13. Blood 116, 5738-5747.
25. De Wilde, V., Van Rompaey, N., Hill, M., Lebrun, J. F., Lemaitre, P., Lhommé, F., Kubjak, C., Vokaer, B., Oldenhove, G., Charbonnier, L. M., Cuturi, M. C., Goldman, M., Le Moine, A. (2009) Endotoxin-induced my-eloid-derived suppressor cells inhibit alloim-mune responses via heme oxygenase-1. Am. J. Transplant. 9, 2034-2047.
26. Lu, T., Ramakrishnan, R., Altiok, S., Youn, J. I., Cheng, P., Celis, E., Pisarev, V., Sherman, S., Sporn, M. B., Gabrilovich, D. (2011) Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice. J. Clin. Invest. 121, 4015-4029.
27. Obermajer, N., Muthuswamy, R., Lesnock, J., Edwards, R. P., Kalinski, P. (2011) Posi tive feedback between PGE2 and COX2 re directs the differentiation of human den dritic cells towards stable myeloid-derived suppressor cells. Blood 118, 5498-5505.